Human Alveolar Epithelial Cell Responses to Core–Shell Superparamagnetic Iron Oxide Nanoparticles (SPIONs)
Source abstract
Abstract
Superparamagnetic iron oxide nanoparticles (SPIONs) have been prepared and coated with positively (-NH3(+)) and negatively (-COO(-)) charged shells. These NPs, as well as their "bare" precursor, which actually contain surface hydroxyl groups, have been characterized in vitro, and their influence on a human epithelial cell line has been assessed in terms of cell metabolic activity, cellular membrane lysis, mitochondrial activity, and reactive oxygen species production. Their physicochemical characterizations and protein-nanoparticle interactions have been determined using dynamic light scattering, high-resolution transmission electron microscopy, matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) spectrometry, and Coomassie Blue fast staining. Cell-SPION interactions have been determined by PrestoBlue resazurin-based, Trypan Blue dye exclusion-based, and MTS cell proliferation assays as well as by reactive oxygen species determination. The results show that different surface characteristics cause different protein corona and cell responses. Some proteins (e.g., albumin) are adsorbed only on positively charged coatings and others (e.g., fibrinogen) only on negatively charged coating. No cell deaths occur, but cell proliferation is influenced by surface chemistry. Proliferation reduction is dose dependent and highest for bare SPIONs. Negatively charged SPIONs were the most biocompatible.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoparticles: synthesis and applications · Graphene and Nanomaterials Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of General, Organic, and Biomedical Chemistry, Nuclear Magnetic Resonance and Molecular Imaging Laboratory, University of Mons, Mons 7000, Belgium
Research Center, Hôpital Sacré-Cœur Montreal, 5400 Boulevard Gouin Ouest, Montréal, Québec H4J 1C5, Canada
Funding
Natural Sciences and Engineering Research Council of Canada · European Cooperation in Science and Technology · Fonds De La Recherche Scientifique - FNRS · Fédération Wallonie-Bruxelles · Fonds de Recherche du Québec-Nature et Technologies · EMIL programs
References (59)
Show source-provided references
1. Fukuda Y. · Magn. Reson. Med. Sci. · 2006 · 5 · 19110.2463/mrms.5.191 ↗
2. Xu H. H. · Biomaterials · 2004 · 25 · 461510.1016/j.biomaterials.2003.12.058 ↗
3. Gupta A. K. · Biomaterials · 2005 · 26 · 399510.1016/j.biomaterials.2004.10.012 ↗
4. Zhao D. L. · J. Alloys Compd. · 2009 · 469 · 21510.1016/j.jallcom.2008.01.083 ↗
5. Chen D. Y. · J. Mater. Chem. · 2010 · 20 · 642210.1039/c0jm00320d ↗
6. Schoepf U. · BioTechniques · 1998 · 24 · 64210.2144/98244rr01 ↗
7. Subbiahdoss G. · Acta Biomater. · 2012 · 8 · 204710.1016/j.actbio.2012.03.002 ↗
8. Lin Y. · J. Environ. Sci. · 2011 · 23 · 4410.1016/S1001-0742(10)60371-3 ↗
9. Stanicki D. · J. Mater. Chem. B · 2014 · 2 · 38710.1039/C3TB21480J ↗
10. Unfried K. · Nanotoxicology · 2007 · 1 · 5210.1080/00222930701314932 ↗
11. Dusinska M. · Nanomed. Nanotechnol. Biol. Med. · 2009 · 4 · 605
12. Albanese A. · Annu. Rev. Biomed. Eng. · 2012 · 14 · 110.1146/annurev-bioeng-071811-150124 ↗
13. Kai W. · Nanoscale Res. Lett. · 2011 · 6 · 48010.1186/1556-276X-6-480 ↗
14. Mahmoudi M. · Chem. Rev. · 2011 · 111 · 561010.1021/cr100440g ↗
15. Rahman M. · 2013 · 1510.1007/978-3-642-37555-2 ↗
16. Solina A. · J. Cardiothorac. Vasc. Anesth. · 2000 · 14 · 1210.1016/S1053-0770(00)90048-X ↗
17. Zhou Z. · Biomacromolecules · 2006 · 7 · 256510.1021/bm060361s ↗
18. Zhang X. F. · Langmuir · 2012 · 28 · 1287910.1021/la302357h ↗
19. Forge D. · J. Phys. Chem. C · 2008 · 112 · 1917810.1021/jp803832k ↗
20. Barick K. C. · J. Magn. Magn. Mater. · 2009 · 321 · 152910.1016/j.jmmm.2009.02.080 ↗
21. Lu X. Y. · Surf. Coat. Tech. · 2007 · 201 · 684310.1016/j.surfcoat.2006.09.019 ↗
22. Mbeh D. A. · J. Biomed. Nanotechnol. · 2014 · 11 · 82810.1166/jbn.2015.2000 ↗
23. Martin-Piedra M. A. · Cytotherapy · 2014 · 16 · 26610.1016/j.jcyt.2013.10.016 ↗
24. Boncler M. · J. Pharmacol. Toxicol. Methods · 2014 · 69 · 910.1016/j.vascn.2013.09.003 ↗
25. Nguyen K. C. · Nanotoxicology · 2013 · 7 · 20210.3109/17435390.2011.648667 ↗
26. Doak S. H. · Mutagenesis · 2009 · 24 · 28510.1093/mutage/gep010 ↗
27. Elbekai R. H. · Free Radicals Biol. Med. · 2005 · 39 · 149910.1016/j.freeradbiomed.2005.07.012 ↗
28. Liu J. F. · Environ. Sci. Technol. · 2008 · 42 · 694910.1021/es800924c ↗
29. Rosenholm J. M. · J. Controlled Release · 2008 · 128 · 15710.1016/j.jconrel.2008.02.013 ↗
30. Mahmoudi M. · J. Colloid Interface Sci. · 2009 · 336 · 51010.1016/j.jcis.2009.04.046 ↗
31. Wang H. · Free Radicals Biol. Med. · 1999 · 27 · 61210.1016/S0891-5849(99)00107-0 ↗
32. Zhang Y. · Biomed. Microdevices · 2004 · 6 · 3310.1023/B:BMMD.0000013363.77466.63 ↗
33. Hong S. C. · Int. J. Nanomed. · 2011 · 6 · 3219
34. Xu M. · Sci. Rep. · 2012 · 2 · 40610.1038/srep00406 ↗
35. Xia T. · ACS Nano · 2008 · 2 · 8510.1021/nn700256c ↗
36. Horie M. · Chem. Res. Toxicol. · 2009 · 22 · 54310.1021/tx800289z ↗
37. Nel A. E. · Nat. Mater. · 2009 · 8 · 54310.1038/nmat2442 ↗
38. Price M. E. · Biochim. Biophys. Acta · 2001 · 1512 · 19110.1016/S0005-2736(01)00330-3 ↗
39. Patel H. M. · Adv. Drug Delivery Rev. · 1998 · 32 · 45
40. Gunawan C. · J. Mater. Chem. B · 2014 · 2 · 206010.1039/c3tb21526a ↗
41. Boratynski J. · Cancer Lett. · 2000 · 148 · 18910.1016/S0304-3835(99)00334-1 ↗
42. Torres A. L. · Acta Biomater. · 2013 · 9 · 655310.1016/j.actbio.2013.01.015 ↗
43. Patel H. M. · Crit. Rev. Ther. Drug Carrier Syst. · 1992 · 9 · 39
44. Ogawara K. · J. Controlled Release · 2004 · 100 · 45110.1016/j.jconrel.2004.07.028 ↗
45. Peng Q. · Biomaterials · 2013 · 34 · 852110.1016/j.biomaterials.2013.07.102 ↗
46. Naqvi S. · Int. J. Nanomed. · 2010 · 5 · 98310.2147/IJN.S13244 ↗
47. Mahmoudi M. · Chem. Rev. · 2012 · 112 · 232310.1021/cr2002596 ↗
48. Ruan J. · Nanoscale Res. Lett. · 2011 · 6 · 29910.1186/1556-276X-6-299 ↗
49. Ankamwar B. · Nanotechnology · 2010 · 21 · 7510210.1088/0957-4484/21/7/075102 ↗
50. Karlsson H. L. · Chem. Res. Toxicol. · 2008 · 21 · 172610.1021/tx800064j ↗
51. Ito A. · Cancer Sci. · 2007 · 98 · 42410.1111/j.1349-7006.2006.00382.x ↗
52. Soenen S. J. · Biomaterials · 2011 · 32 · 19510.1016/j.biomaterials.2010.08.075 ↗
53. Hussain S. M. · Toxicol. In Vitro · 2005 · 19 · 97510.1016/j.tiv.2005.06.034 ↗
54. Berry C. C. · Biomaterials · 2003 · 24 · 455110.1016/S0142-9612(03)00237-0 ↗
55. Gupta A. K. · Biomaterials · 2005 · 26 · 156510.1016/j.biomaterials.2004.05.022 ↗
56. Jeng H. A. · J. Environ. Sci. Health, Part A: Toxic/Hazard. Subst. Environ. Eng. · 2006 · 41 · 269910.1080/10934520600966177 ↗
57. Klein S. · Biochem. Biophys. Res. Commun. · 2012 · 425 · 39310.1016/j.bbrc.2012.07.108 ↗
58. Bae J. E. · Biomaterials · 2011 · 32 · 940110.1016/j.biomaterials.2011.08.075 ↗
59. Mahmoudi M. · Nanoscale · 2012 · 4 · 546110.1039/c2nr31185b ↗